Henry Schein Inc - HSIC STOCK NEWS

Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, announced its participation in three virtual investor conferences in December 2021. The events include the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1, Nasdaq's 44th Virtual Investor Conference at 11:30 a.m. ET on December 2, and the Evercore ISI 4th Annual HealthCONx Virtual Conference at 1:00 p.m. ET on the same day. Live webcasts of the two latter presentations will be accessible to registered attendees.

Henry Schein Cares Foundation, in collaboration with the UPS Foundation, announced the third phase of the "Wearing is Caring" campaign aimed at promoting health equity and access to COVID-19 vaccines. Launched in October 2020, the initiative addresses healthcare disparities in underserved communities. A CDC report indicates that only 56% of Americans are fully vaccinated, with lower rates among minority groups. The campaign emphasizes the role of primary care physicians in vaccination decisions, with 88% of survey respondents citing their doctor’s advice as influential.

Zimbis has launched a partnership with Southern Anesthesia & Surgical (SAS) to enhance medication and supply management for dental professionals. This collaboration introduces an order integration system that streamlines inventory management, allowing automatic population of product reorder information on SAS's website. By improving operational efficiencies, this partnership aims to enable dental surgeons to focus more on patient care. Both companies anticipate that this integration will significantly benefit the dental surgery market.

Henry Schein reported record third-quarter net sales of $3.2 billion, marking an 11.9% increase year-over-year. GAAP diluted EPS rose to $1.15 from $0.99, while non-GAAP diluted EPS reached $1.10, up from $1.03. The company raised its 2021 non-GAAP diluted EPS guidance to between $4.27 and $4.35, reflecting a growth of 44% to 46% compared to 2020. Preliminary guidance for 2022 indicates mid to high single-digit growth over the 2021 guidance. Strong sales growth was seen across Global Dental and Medical segments.

Henry Schein (Nasdaq: HSIC), a leading provider of health care solutions, has committed to a long-term goal of net-zero emissions by 2050. The company has signed the Business Ambition for 1.5⁰C initiative, aiming to set science-based emissions reduction targets. This move is part of a broader strategy to address climate change and improve sustainability within the health care supply chain. Henry Schein will focus on establishing emissions metrics across key markets in North America, Europe, and Australia.

Henry Schein (Nasdaq: HSIC) announced its support for two Mission of Mercy events in Pittsburgh, PA (10/22-10/23) and Phoenix, AZ (12/9-12/11) as part of a three-year commitment to America's Dentists Care Foundation (ADCF). The company will donate up to $600,000 in health care products to provide free oral care to underserved communities. Each clinic can treat about 70 patients per hour, offering roughly $500 in free dental care per patient. This initiative aims to enhance health equity and access to oral care.

Henry Schein, the leading provider of health care solutions for dental and medical practitioners, will present virtually at the Credit Suisse 30th Annual Healthcare Conference on November 9, 2021, at 10:30 am Eastern time. The presentation will be available via live webcast at www.henryschein.com/IRwebcasts, with a replay accessible afterward. As a FORTUNE 500 Company, Henry Schein operates in 32 countries, serving over 1 million customers with more than 300 solutions for improved operational success.

Henry Schein, the leading provider of health care solutions, will release its third quarter 2021 financial results before the market opens on November 2, 2021. A live webcast of its earnings conference call will begin at 10:00 a.m. Eastern time the same day. Key speakers include Stanley M. Bergman, Chairman and CEO, and Steven Paladino, CFO. Investors can access the call at www.henryschein.com/IRwebcasts. Henry Schein operates globally with over 21,000 team members and reported sales of $10.1 billion in 2020.

Henry Schein supports a coalition of physician organizations urging the Biden Administration to expedite access to COVID-19 vaccines for primary-care physicians. CEO Stanley M. Bergman highlighted ongoing vaccination challenges in communities of color and rural areas, emphasizing the role of trusted office-based physicians in addressing vaccine hesitancy. The push aims to close vaccination gaps as the CDC updates guidance allows for simultaneous administration of flu and COVID-19 vaccines. The company continues to focus on health equity amidst efforts to improve vaccine distribution.